These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15144434)

  • 1. Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations.
    Magaudda A; Gelisse P; Genton P
    Epilepsia; 2004 Jun; 45(6):678-81. PubMed ID: 15144434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimyoclonic effect of levetiracetam.
    Genton P; Gélisse P
    Epileptic Disord; 2000 Dec; 2(4):209-12. PubMed ID: 11174151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of efficacy and potential aggravation of myoclonus with lamotrigine in Unverricht-Lundborg disease.
    Genton P; Gelisse P; Crespel A
    Epilepsia; 2006 Dec; 47(12):2083-5. PubMed ID: 17201707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical picture of EPM1-Unverricht-Lundborg disease.
    Kälviäinen R; Khyuppenen J; Koskenkorva P; Eriksson K; Vanninen R; Mervaala E
    Epilepsia; 2008 Apr; 49(4):549-56. PubMed ID: 18325013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
    Perry MS; Benatar M
    Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of levetiracetam in hospitalized patients.
    Falip M; Carreño M; Amaro S; Donaire A; Delgado R; Toledo M; Maestro I
    Epilepsia; 2006 Dec; 47(12):2186-8. PubMed ID: 17201722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam as a treatment option in non-convulsive status epilepticus.
    Rupprecht S; Franke K; Fitzek S; Witte OW; Hagemann G
    Epilepsy Res; 2007 Mar; 73(3):238-44. PubMed ID: 17161587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unverricht-Lundborg disease, a condition with self-limited progression: long-term follow-up of 20 patients.
    Magaudda A; Ferlazzo E; Nguyen VH; Genton P
    Epilepsia; 2006 May; 47(5):860-6. PubMed ID: 16686650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of age and comedication on levetiracetam pharmacokinetics and tolerability.
    Hirsch LJ; Arif H; Buchsbaum R; Weintraub D; Lee J; Chang JT; Resor SR; Bazil CW
    Epilepsia; 2007 Jul; 48(7):1351-9. PubMed ID: 17573925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study.
    Striano P; Manganelli F; Boccella P; Perretti A; Striano S
    Mov Disord; 2005 Dec; 20(12):1610-4. PubMed ID: 16078205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot open-label trial of zonisamide in Unverricht-Lundborg disease.
    Italiano D; Pezzella M; Coppola A; Magaudda A; Ferlazzo E; Bramanti P; Striano S; Zara F; Striano P
    Mov Disord; 2011 Feb; 26(2):341-3. PubMed ID: 20939070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA).
    Stefan H; Wang-Tilz Y; Pauli E; Dennhöfer S; Genow A; Kerling F; Lorber B; Fraunberger B; Halboni P; Koebnick C; Gefeller O; Tilz C
    Epilepsia; 2006 Mar; 47(3):516-22. PubMed ID: 16529615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.
    von Stuelpnagel C; Holthausen H; Kluger G
    Eur J Paediatr Neurol; 2007 Nov; 11(6):341-5. PubMed ID: 17442601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
    Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimyoclonic effect of levetiracetam in MERRF syndrome.
    Mancuso M; Galli R; Pizzanelli C; Filosto M; Siciliano G; Murri L
    J Neurol Sci; 2006 Apr; 243(1-2):97-9. PubMed ID: 16414077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam in three cases of progressive myoclonus epilepsy.
    Papacostas S; Kkolou E; Papathanasiou E
    Pharm World Sci; 2007 Jun; 29(3):164-6. PubMed ID: 17242859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures.
    Baulac M; Brodie MJ; Elger CE; Krakow K; Stockis A; Meyvisch P; Falter U
    Epilepsia; 2007 Mar; 48(3):589-92. PubMed ID: 17326794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history of Unverricht-Lundborg disease: a report of eight genetically proven cases.
    Chew NK; Mir P; Edwards MJ; Cordivari C; Martino D; Schneider SA; Kim HT; Quinn NP; Bhatia KP
    Mov Disord; 2008 Jan; 23(1):107-13. PubMed ID: 17994572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical predictors in patients with refractory epilepsy exposed to levetiracetam: a single-center study.
    Peltola J; Peltola M; Auvinen A; Keränen T; Liimatainen S; Kharazmi E; Fallah M
    Acta Neurol Scand; 2008 May; 117(5):332-6. PubMed ID: 18081915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.